US Broker Ratings

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 24.58% Potential Upside in the Biotech Sector

Sarepta Therapeutics, Inc. (SRPT) stands at the forefront of the biotechnology industry with a keen focus on developing RNA-targeted therapeutics and genetic therapies for rare diseases. Based in Cambridge, Massachusetts,..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Uncovering a 25.7% Potential Upside for Investors

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands out in the biotechnology sector with a robust market capitalization of $110.9 billion. This healthcare giant, headquartered in Boston, Massachusetts, has carved a niche..

Tempus AI, Inc. (TEM) Investor Outlook: Navigating the 52.97% Potential Upside in Health Information Services

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector with its comprehensive suite of diagnostic and data-driven solutions aimed at revolutionizing precision medicine. As a notable..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Look at Growth Potential and Analyst Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector specializing in medical instruments and supplies, is drawing attention from investors with its robust growth potential and..

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech with 102.54% Potential Upside

As investors scour the healthcare sector for promising opportunities, ADMA Biologics Inc (NASDAQ: ADMA) has emerged as a noteworthy contender in the biotechnology space. With a market capitalization of $1.92..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings Signal Promising Growth Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stands out in the biotech sector, not just for its extensive portfolio of innovative therapies but also for its strong market performance and promising growth..

Alkermes plc (ALKS) Stock Analysis: Uncovering a 21% Upside Potential in Biopharmaceutical Innovation

Alkermes plc (NASDAQ: ALKS) is catching the attention of investors, with a compelling 21.23% potential upside as per the latest analyst ratings. This Dublin-based biopharmaceutical company is not only making..

Waystar Holding Corp. (WAY) Stock Analysis: Assessing the 93.75% Upside Potential

Waystar Holding Corp. (WAY), a key player in the Health Information Services industry, is capturing attention with an impressive potential upside of 93.75%, according to analyst ratings. As a cloud-based..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Growth with a 52.60% Revenue Surge

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare plans industry, is gaining attention with its impressive revenue growth of 52.60%. As a healthcare technology company, Oscar Health..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Unlocking a 39.52% Potential Upside with Robust Buy Ratings

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $162.9 billion, the..

Stevanato Group S.p.A. (STVN) Stock Analysis: A 38% Potential Upside Draws Investor Attention

Stevanato Group S.p.A. (NYSE: STVN) is capturing the attention of investors with its robust presence in the healthcare sector, particularly within the medical instruments and supplies industry. With a significant..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 10.76% Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors with its potential upside of 10.76%. Headquartered in..

Prestige Consumer Healthcare (PBH): Investor Outlook Reveals 48.88% Potential Upside

Investors with an eye on the healthcare sector may find Prestige Consumer Healthcare Inc. (NYSE: PBH) a compelling opportunity, as the stock currently suggests a notable potential upside of 48.88%..

Halozyme Therapeutics (HALO) Stock Analysis: A 27.3% Upside Potential Amid Strong Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing investor attention with its robust growth prospects and potential upside. With a market capitalization of $7.96..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 15.23% Potential Upside Amid Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, is attracting considerable attention from investors with a compelling 15.23% potential upside based on its current trading metrics. With a..

Illumina, Inc. (ILMN)

⚠️ No article content returned.

..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Compelling 86% Upside Potential for Innovative Healthcare Investors

TransMedics Group, Inc. (TMDX), a pioneering force in the healthcare sector, specifically in medical devices, is capturing the attention of investors with its innovative approach to organ transplant therapy. Headquartered..

iRhythm Holdings, Inc. (IRTC) Investor Outlook: Unlocking 61.53% Potential Upside in Medical Devices

iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing the attention of investors with a promising potential upside of 61.53%. Specializing in the healthcare sector, particularly within the medical devices industry, iRhythm..

Vaxcyte, Inc. (PCVX) Stock Analysis: Biotech Innovator with Over 100% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX), a pioneering force in the biotechnology sector, is making waves with its ambitious efforts to develop next-generation vaccines targeting bacterial infectious diseases. Headquartered in San Carlos,..

Humana Inc. (HUM) Stock Analysis: Navigating Healthcare with a Solid Revenue Growth of 23.5%

Humana Inc. (HUM), a prominent player in the U.S. healthcare sector, operates primarily within the healthcare plans industry. With a market capitalization of $36.63 billion, Humana stands as a significant..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds